Maximum Gabapentin Dose
For adults with normal renal function (CrCl ≥60 mL/min), the maximum gabapentin dose is 3600 mg/day divided into three doses, while patients with impaired renal function require substantial dose reductions based on creatinine clearance, with maximum doses ranging from 1400 mg/day (CrCl 30-59 mL/min) down to 300 mg/day (CrCl <15 mL/min). 1
Normal Renal Function (CrCl ≥60 mL/min)
The FDA-approved maximum dose is 3600 mg/day, administered as 1200 mg three times daily. 1
Start at 300 mg three times daily (900 mg/day total) and titrate upward by 300 mg/day every 1-7 days as tolerated. 2, 1
Most patients achieve adequate pain relief at 1800 mg/day, and doses above this threshold do not consistently provide additional benefit but do increase adverse effects. 2
The maximum interval between doses should not exceed 12 hours to maintain therapeutic levels. 1
Impaired Renal Function: Dose Reduction Algorithm
Gabapentin is eliminated entirely unchanged by the kidneys, making dose adjustment mandatory in renal impairment to prevent toxicity. 2, 1
CrCl 30-59 mL/min (Moderate Impairment)
Maximum dose: 1400 mg/day divided into two daily doses (700 mg twice daily). 1
Start at 100-200 mg/day (or 100 mg at bedtime for 3-7 days), then increase by 100-300 mg every 3-7 days as tolerated. 3
This represents at least a 50% reduction from standard dosing. 3
CrCl 15-29 mL/min (Severe Impairment)
Maximum dose: 700 mg/day as a single daily dose. 1
Start at 100 mg daily and titrate cautiously every 3-7 days. 3
CrCl <15 mL/min (End-Stage Renal Disease)
Maximum dose: 300 mg/day as a single daily dose. 1
For patients on hemodialysis: Give a loading dose of 300-400 mg, then 200-300 mg after each 4-hour hemodialysis session. 1, 4
The elimination half-life increases dramatically to 132 hours in anuric patients (compared to 5-7 hours in normal renal function), necessitating these extreme reductions. 4
Critical Dosing Pitfalls
The most common prescribing error is failing to calculate creatinine clearance accurately, particularly in elderly patients with reduced muscle mass, where serum creatinine alone significantly underestimates renal impairment. 3
Always use the Cockcroft-Gault equation to calculate CrCl before initiating therapy: CrCl (mL/min) = [(140 - age) × weight (kg)] / [72 × serum creatinine (mg/dL)] (multiply by 0.85 for females). 1
Do not rely on serum creatinine alone—a "normal" creatinine of 1.0 mg/dL in an 80-year-old patient weighing 60 kg corresponds to a CrCl of approximately 40 mL/min, requiring dose reduction. 3
Elderly patients often achieve pain relief at lower doses (400-900 mg/day) than younger adults, so aggressive titration to maximum doses is rarely necessary. 3
Toxicity Recognition
Common manifestations of gabapentin toxicity in renal impairment include altered mental status, confusion with hallucinations, myoclonus, tremulousness, dizziness, somnolence, and in severe cases, coma. 3
These symptoms typically emerge when doses are not adjusted for renal function and can lead to falls, fractures, and preventable morbidity. 3
If acute kidney injury develops during treatment, temporarily discontinue gabapentin in patients with baseline CrCl <60 mL/min until renal function stabilizes. 5
Titration Strategy
For normal renal function: Increase by 300 mg/day every 1-7 days. 1
For any degree of renal impairment: Increase by 100-300 mg every 3-7 days (slower titration) to minimize dose-dependent dizziness and sedation. 3
An adequate trial requires 3-8 weeks for titration plus 2 weeks at the maximum tolerated dose before concluding treatment failure. 2